Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms

por Secardin, Lise, Gomez Limia, Cintia, da Silva-Benedito, Suzana, Lordier, Larissa, El-Khoury, Mira, Marty, Caroline, Ianotto, Jean-Christophe, Raslova, Hana, Constantinescu, Stefan N., Bonamino, Martín Hernán, Vainchenker, William, Monte-Mor, Barbara, Di Stefano, Antonio, Plo, Isabelle
Publicado 2021